Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Stojdl

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Human Gene Therapy|September 9, 2004
Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancyBrian D Lichty, David F Stojdl, Rebecca A Taylor, et al.
Molecular Therapy Oncolytics|October 25, 2017
Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the BrainLukxmi Balathasan, Vera A Tang, Beta Yadollahi, et al.
International Journal of Cancer|June 27, 2012
Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosumJan Brun, Douglas J Mahoney, Fabrice Le Boeuf, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysisFethia Ben Yebdri, Julien Van Grevenynghe, Vera A Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Identification of genetically modified Maraba virus as an oncolytic rhabdovirusJan Brun, Dan McManus, Charles Lefebvre, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunityAnthony T Power, Jiahu Wang, Theresa J Falls, et al.
Oncotarget|December 15, 2016
Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine modelChristine C Dobson, Thet Naing, Shawn T Beug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamideXue Qing Lun, Ji-Hyun Jang, Nan Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2013
Maraba virus as a potent oncolytic vaccine vectorJonathan G Pol, Liang Zhang, Byram W Bridle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2007
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flowCaroline J Breitbach, Jennifer M Paterson, Chantal G Lemay, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Human Gene Therapy|September 9, 2004
Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancyBrian D Lichty, David F Stojdl, Rebecca A Taylor, et al.
Molecular Therapy Oncolytics|October 25, 2017
Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the BrainLukxmi Balathasan, Vera A Tang, Beta Yadollahi, et al.
International Journal of Cancer|June 27, 2012
Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosumJan Brun, Douglas J Mahoney, Fabrice Le Boeuf, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysisFethia Ben Yebdri, Julien Van Grevenynghe, Vera A Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Identification of genetically modified Maraba virus as an oncolytic rhabdovirusJan Brun, Dan McManus, Charles Lefebvre, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunityAnthony T Power, Jiahu Wang, Theresa J Falls, et al.
Oncotarget|December 15, 2016
Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine modelChristine C Dobson, Thet Naing, Shawn T Beug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamideXue Qing Lun, Ji-Hyun Jang, Nan Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2013
Maraba virus as a potent oncolytic vaccine vectorJonathan G Pol, Liang Zhang, Byram W Bridle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2007
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flowCaroline J Breitbach, Jennifer M Paterson, Chantal G Lemay, et al.
Pageof 4